Simplex Trading’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-233,626
| Closed | -$814K | – | 10181 |
|
|
2023
Q4 | $712K | Buy |
233,626
+216,146
| +1,237% | +$406K | ﹤0.01% | 3356 |
|
|
2023
Q3 | $25K | Buy |
+17,480
| New | +$33.8K | ﹤0.01% | 6448 |
|
|
2023
Q1 | – | Sell |
-9,496
| Closed | -$45.6K | – | 10400 |
|
|
2022
Q4 | $51K | Sell |
9,496
-10,005
| -51% | -$83.8K | ﹤0.01% | 5887 |
|
|
2022
Q3 | $243K | Buy |
+19,501
| New | +$223K | ﹤0.01% | 4366 |
|
|
2022
Q1 | – | Sell |
-3,716
| Closed | -$35.2K | – | 11625 |
|
|
2021
Q4 | $37K | Buy |
3,716
+2,932
| +374% | +$37.4K | ﹤0.01% | 7648 |
|
|
2021
Q3 | $17K | Buy |
784
+52
| +7% | +$847 | ﹤0.01% | 8584 |
|
|
2021
Q2 | $16K | Sell |
732
-22,306
| -97% | -$495K | ﹤0.01% | 8791 |
|
|
2021
Q1 | $554K | Sell |
23,038
-3,458
| -13% | -$80.4K | ﹤0.01% | 3224 |
|
|
2020
Q4 | $476K | Buy |
26,496
+26,340
| +16,885% | +$394K | ﹤0.01% | 3489 |
|
|
2020
Q3 | $1K | Sell |
156
-169
| -52% | -$2.79K | ﹤0.01% | 7617 |
|
|
2020
Q2 | $7K | Buy |
+325
| New | +$5.37K | ﹤0.01% | 6851 |
|
|
2020
Q1 | – | Sell |
-197
| Closed | -$3.68K | – | 8440 |
|
|
2019
Q4 | $5K | Sell |
197
-910
| -82% | -$21.3K | ﹤0.01% | 6725 |
|
|
2019
Q3 | $25K | Buy |
1,107
+1,041
| +1,577% | +$32.8K | ﹤0.01% | 5657 |
|
|
2019
Q2 | $2K | Buy |
+66
| New | +$1.39K | ﹤0.01% | 6792 |
|
|
2019
Q1 | – | Sell |
-100
| Closed | -$1K | – | 8042 |
|
|
2018
Q4 | $1K | Buy |
+100
| New | +$3.75K | ﹤0.01% | 6815 |
|
Simplex Trading's GTHX Position: Q1 2024 in Review
Simplex Trading sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2024, closing a stake of 233,626 shares — an estimated $814K sold.
Simplex Trading first reported a position in GTHX in Q4 2018 and held it in 15 quarters. The position peaked at $712K in Q4 2023. 86 funds tracked by Wall St. Rank hold GTHX as of Q1 2024.
- Simplex Trading reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Simplex Trading sold 233,626 G1 Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $814K.
- Simplex Trading first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2018 and held it in 15 quarters.
- Simplex Trading's G1 Therapeutics, Inc. Common Stock position peaked at $712K in Q4 2023.
- 86 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.